These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 30073275)
1. Association of Statin Exposure With Histologically Confirmed Idiopathic Inflammatory Myositis in an Australian Population. Caughey GE; Gabb GM; Ronson S; Ward M; Beukelman T; Hill CL; Limaye V JAMA Intern Med; 2018 Sep; 178(9):1224-1229. PubMed ID: 30073275 [TBL] [Abstract][Full Text] [Related]
2. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients. Nichols GA; Koro CE Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557 [TBL] [Abstract][Full Text] [Related]
3. Statin use in patients with non-HMGCR idiopathic inflammatory myopathies: A retrospective study. Bae SS; Oganesian B; Golub I; Charles-Schoeman C Clin Cardiol; 2020 Jul; 43(7):732-742. PubMed ID: 32432360 [TBL] [Abstract][Full Text] [Related]
5. Mortality and its predominant causes in a large cohort of patients with biopsy-determined inflammatory myositis. Limaye V; Hakendorf P; Woodman RJ; Blumbergs P; Roberts-Thomson P Intern Med J; 2012 Feb; 42(2):191-8. PubMed ID: 21118413 [TBL] [Abstract][Full Text] [Related]
6. Is statin-induced myositis part of the polymyositis disease spectrum? Albayda J; Mammen AL Curr Rheumatol Rep; 2014 Aug; 16(8):433. PubMed ID: 24996782 [TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy. Limaye V; Bundell C; Hollingsworth P; Rojana-Udomsart A; Mastaglia F; Blumbergs P; Lester S Muscle Nerve; 2015 Aug; 52(2):196-203. PubMed ID: 25521389 [TBL] [Abstract][Full Text] [Related]
8. Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum". Hamann PD; Cooper RG; McHugh NJ; Chinoy H Autoimmun Rev; 2013 Oct; 12(12):1177-81. PubMed ID: 23851103 [TBL] [Abstract][Full Text] [Related]
9. Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study. Pedro-Botet J; Millán Núñez-Cortés J; Chillarón JJ; Flores-Le Roux JA; Rius J Expert Opin Drug Saf; 2016 Dec; 15(12):1583-1587. PubMed ID: 27645494 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of polymyalgia rheumatica in a cohort of patients with idiopathic inflammatory myopathy. Douglass-Molloy H; Limaye V Clin Rheumatol; 2020 Apr; 39(4):1217-1221. PubMed ID: 31919772 [TBL] [Abstract][Full Text] [Related]
11. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study. Musset L; Allenbach Y; Benveniste O; Boyer O; Bossuyt X; Bentow C; Phillips J; Mammen A; Van Damme P; Westhovens R; Ghirardello A; Doria A; Choi MY; Fritzler MJ; Schmeling H; Muro Y; García-De La Torre I; Ortiz-Villalvazo MA; Bizzaro N; Infantino M; Imbastaro T; Peng Q; Wang G; Vencovský J; Klein M; Krystufkova O; Franceschini F; Fredi M; Hue S; Belmondo T; Danko K; Mahler M Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568 [TBL] [Abstract][Full Text] [Related]
13. HMGCR-associated myositis: a New Zealand case series and estimate of incidence. Kennedy N; Keating P; O'Donnell J Intern Med J; 2016 May; 46(5):622-5. PubMed ID: 27170241 [TBL] [Abstract][Full Text] [Related]
14. Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology-proven cases. Tan JA; Roberts-Thomson PJ; Blumbergs P; Hakendorf P; Cox SR; Limaye V Int J Rheum Dis; 2013 Jun; 16(3):331-8. PubMed ID: 23981756 [TBL] [Abstract][Full Text] [Related]
15. Necrotizing Autoimmune myopathy: A case report on statin induced rhabdomyolysis requiring immunosuppressive therapy. Kunwar S; Parekh JD; Chilukuri RS; Andukuri VA Drug Discov Ther; 2018; 12(5):315-317. PubMed ID: 30464165 [TBL] [Abstract][Full Text] [Related]
16. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis. Koro CE; Sowell MO; Stender M; Qizilbash N Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791 [TBL] [Abstract][Full Text] [Related]
17. Statins as a possible cause of inflammatory and necrotizing myopathies. Padala S; Thompson PD Atherosclerosis; 2012 May; 222(1):15-21. PubMed ID: 22154355 [TBL] [Abstract][Full Text] [Related]
18. Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus. Limaye VS; Lester S; Blumbergs P; Roberts-Thomson PJ Int J Rheum Dis; 2010 May; 13(2):132-7. PubMed ID: 20536597 [TBL] [Abstract][Full Text] [Related]
19. Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population. McClure DL; Valuck RJ; Glanz M; Murphy JR; Hokanson JE J Clin Epidemiol; 2007 Aug; 60(8):812-8. PubMed ID: 17606177 [TBL] [Abstract][Full Text] [Related]